tiprankstipranks
Advertisement
Advertisement

DE:IKAP Stock Latest News

Closing Bell Movers: Nordson up 8% after Q3 earnings beat
The FlyClosing Bell Movers: Nordson up 8% after Q3 earnings beat
12d ago
AUPH
BEEM
Aurinia, Teva Reach Voclosporin Patent Litigation Settlement
PremiumCompany Announcements
Aurinia, Teva Reach Voclosporin Patent Litigation Settlement
12d ago
8K
AUPH
Aurinia settles patent litigation with Teva
PremiumThe Fly
Aurinia settles patent litigation with Teva
12d ago
AUPH
TEVA
Aurinia Pharmaceuticals price target raised to $16 from $15 at RBC Capital
PremiumThe Fly
Aurinia Pharmaceuticals price target raised to $16 from $15 at RBC Capital
25d ago
AUPH
Aurinia Posts Strong Q2 2026 Results on Rising LUPKYNIS Sales
PremiumCompany Announcements
Aurinia Posts Strong Q2 2026 Results on Rising LUPKYNIS Sales
25d ago
AUPH
Aurinia Posts Strong Q2 Results, Reaffirms 2026 Outlook and Advances Autoimmune Pipeline
PremiumCompany AnnouncementsAurinia Posts Strong Q2 Results, Reaffirms 2026 Outlook and Advances Autoimmune Pipeline
25d ago
AUPH
Aurinia Pharmaceuticals sees FY26 revenue $315M-$325M, consensus $325.82M
Premium
The Fly
Aurinia Pharmaceuticals sees FY26 revenue $315M-$325M, consensus $325.82M
26d ago
AUPH
Aurinia Pharmaceuticals reports Q2 EPS 28c, consensus 24c
Premium
The Fly
Aurinia Pharmaceuticals reports Q2 EPS 28c, consensus 24c
26d ago
AUPH
Aurinia Pharmaceuticals (AUPH) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Aurinia Pharmaceuticals (AUPH) Q2 Earnings Cheat Sheet
1M ago
AUPH
Aurinia Pharmaceuticals announces initiation of PRESERVE study
PremiumThe Fly
Aurinia Pharmaceuticals announces initiation of PRESERVE study
2M ago
AUPH
Aurinia Shareholders Back Board Slate and Governance Measures
PremiumCompany Announcements
Aurinia Shareholders Back Board Slate and Governance Measures
3M ago
8K
AUPH
Aurinia presents new analysis of AURORA 1 Phase 3 study of Lupkynis
PremiumThe Fly
Aurinia presents new analysis of AURORA 1 Phase 3 study of Lupkynis
3M ago
AUPH
Morning Movers: Macy’s and Medtronic rise after quarterly reports
PremiumThe FlyMorning Movers: Macy’s and Medtronic rise after quarterly reports
3M ago
M
GME
Aurinia Pharmaceuticals up 4% in pre-market after insider transactions
Premium
The Fly
Aurinia Pharmaceuticals up 4% in pre-market after insider transactions
3M ago
AUPH
Aurinia Pharmaceuticals Completes Acquisition of Kezar Life Sciences
Premium
Company Announcements
Aurinia Pharmaceuticals Completes Acquisition of Kezar Life Sciences
4M ago
8K
AUPH
Aurinia Pharmaceuticals reports Q1 EPS 25c, consensus 20c
PremiumThe Fly
Aurinia Pharmaceuticals reports Q1 EPS 25c, consensus 20c
4M ago
AUPH
Aurinia backs FY26 revenue view $315M-$325M, consensus $326.22M
PremiumThe Fly
Aurinia backs FY26 revenue view $315M-$325M, consensus $326.22M
4M ago
AUPH
Aurinia Pharmaceuticals to Acquire Kezar, Expanding Autoimmune Pipeline
PremiumCompany Announcements
Aurinia Pharmaceuticals to Acquire Kezar, Expanding Autoimmune Pipeline
5M ago
8K
AUPH
Kezar Life Sciences takeover valuation ‘makes sense,’ says Jefferies
PremiumThe Fly
Kezar Life Sciences takeover valuation ‘makes sense,’ says Jefferies
5M ago
KZR
AUPH
Midday Fly By: Sysco buying Restaurant Depot, Uber to acquire Blacklane
PremiumThe FlyMidday Fly By: Sysco buying Restaurant Depot, Uber to acquire Blacklane
5M ago
IQ
SR
Aurinia to Buy Kezar Life Sciences in Cash-and-CVR Autoimmune Deal
Premium
Company Announcements
Aurinia to Buy Kezar Life Sciences in Cash-and-CVR Autoimmune Deal
5M ago
AUPH
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
Premium
The Fly
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
5M ago
KZR
AUPH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >